OCS
OCS
NASDAQ · Pharmaceuticals

Oculis Holding Ag

$6.83
-0.45 (-6.18%)
As of Nov 7, 1:48 AM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +299.9% upside
Low Target $14.95
Average Target $27.31
High Target $37.18
Current Price $6.83
Current
$6.83
Target
$27.31
$14.95 $27.31 avg $37.18
Scenario Analysis
Bear Case
$14.95
118.9%
Low target
Base Case
$27.31
+299.9%
Avg target
Bull Case
$37.18
+444.4%
High target
Risk/Reward
3.7x
Highly favorable
Price in Context
52-Week High
$34.48
-80.2% from high
52-Week Low
$6.78
+0.7% from low
Target vs 52W High
$27.31
-20.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%